We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Chlamydia May Lurk in the Intestines

Immunofluorescence staining of human gastric cells grown in a microplate and infected with Chlamydia trachomatis.
Credit: Pargev Hovhannisyan / University of Wuerzburg.
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 2 minutes

Summary 

Research from Germany suggests that chlamydia bacteria may persist in the intestines after antibiotic treatment, hiding in this niche and potentially causing recurrent infections. Using intestinal organoids, researchers found chlamydia could enter the gut from the bloodstream, highlighting the need for further studies to understand how the bacteria evade treatment.

Key Takeaways

  • Persistence Phenomenon: Even after successful antibiotic treatment, chlamydia can persist in the intestines, leading to reinfections.
  • Intestinal Reservoir: Studies on organoids revealed that chlamydia can infect the intestines via the bloodstream and form resistant, persistent bacteria.
  • Future Research: Researchers aim to explore which specific intestinal cell types chlamydia targets and how surrounding tissue factors contribute to bacterial persistence.
  • People who are infected with chlamydia can transmit these bacteria to other people during unprotected sex. The pathogens usually cause no or only mild symptoms at first, such as itching in the vagina, penis or anus. If the infection is noticed, it can be easily treated with antibiotics. If this does not happen, the bacteria can cause serious problems, including infertility and cancer.


    A phenomenon is known from everyday clinical practice that can occur after successful antibiotic treatment: when people who have already been treated come to the doctor with a new chlamydia infection, they are often infected with exactly the same strains of bacteria as the previous infection.


    "It is therefore reasonable to assume that the bacteria find a niche in the body where they are not yet vulnerable, that they form a permanent reservoir there and can become active again later," says Professor Thomas Rudel, chlamydia expert and Head of the Chair of Microbiology at the Biocentre of Julius-Maximilians-Universität (JMU) Würzburg in Bavaria, Germany. This phenomenon is known as persistence. It is problematic because the chlamydia that persist in the body become increasingly resistant to antibiotics over time.

    Want more breaking news?

    Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day.

    Subscribe for FREE

    Intestinal Organoids Experimentally Infected with Chlamydia

    In which niche do the bacteria persist? Experiments on mouse models have shown that chlamydia can persist in the intestines of animals. And in humans, too, the bacteria seem to make themselves at home in precisely this place. This is reported by the research groups of Thomas Rudel and Sina Bartfeld in the journal PLOS Pathogens. Professor Bartfeld worked at JMU until 2021; she now heads the Department of Medical Biotechnology at Technische Universität Berlin.


    The researchers identified the intestine as a niche with the help of artificial organs in miniature format, so-called organoids. These are structures produced in the laboratory from human intestinal cells that are very similar in structure and function to the model organ.


    The teams from Würzburg and Berlin tried to infect the intestinal organoids with chlamydia. They discovered that the inner cell layer of the organoids is very resistant to the bacteria: the pathogens could only penetrate there if the cell epithelium was damaged. From the blood side, however, the chlamydia were able to infect very efficiently. "In this case, we repeatedly found the persistent forms of the bacteria, which can be clearly identified with their typical shape under the electron microscope," says JMU researcher Pargev Hovhannisyan, first author of the publication.

    Clinical Studies and Further Experiments Must Follow

    Transferred to the human organism, this would mean that chlamydia infection with subsequent persistence can only occur with difficulty via the inner side of the intestine, but very easily via the blood. However, whether this actually happens in the human body has yet to be confirmed in clinical studies, says Thomas Rudel.


    The next step for Thomas Rudel and Sina Bartfeld is to to find out whether the chlamydia select certain cell types for their persistence – no easy task, as the intestine consists of hundreds of different cell types. But perhaps it is also factors from the surrounding tissue that trigger persistence. These and other details are now to be investigated.


    Reference: Hovhannisyan P, Stelzner K, Keicher M, et al. Infection of human organoids supports an intestinal niche for Chlamydia trachomatis. Zhong G, ed. PLoS Pathog. 2024;20(8):e1012144. doi: 10.1371/journal.ppat.1012144


    This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source. Our press release publishing policy can be accessed here.


    This content includes text that has been generated with the assistance of AI. Technology Networks' AI policy can be found here.